Report Detail

Other Global (United States, European Union and China) Osteoarthritis Pain Market Research Report 2019-2025

  • RnM3617736
  • |
  • 29 July, 2019
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Other

Osteoarthritis, the most common type of arthritis, is a leading cause of disability.
It is also known as degenerative joint disease, hypertrophic arthritis, and degenerative arthritis, and is most commonly prevalent in older (above 60 years of age) and middle-aged people (between 40-59 years of age).
In 2019, the market size of Osteoarthritis Pain is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Osteoarthritis Pain.

This report studies the global market size of Osteoarthritis Pain, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Osteoarthritis Pain production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Abbott Laboratories
Johnson & Johnson
Novartis International
Pfizer
AbbVie
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
Crystal Genomics
Cytori Therapeutics

Market Segment by Product Type
Oral
Non-Oral

Market Segment by Application
Hospital
Pharmacy
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Osteoarthritis Pain status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Osteoarthritis Pain manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Osteoarthritis Pain are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Osteoarthritis Pain Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Oral
      • 1.3.3 Non-Oral
    • 1.4 Market Segment by Application
      • 1.4.1 Global Osteoarthritis Pain Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Pharmacy
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Osteoarthritis Pain Production Value 2014-2025
      • 2.1.2 Global Osteoarthritis Pain Production 2014-2025
      • 2.1.3 Global Osteoarthritis Pain Capacity 2014-2025
      • 2.1.4 Global Osteoarthritis Pain Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Osteoarthritis Pain Market Size CAGR of Key Regions
      • 2.2.2 Global Osteoarthritis Pain Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Osteoarthritis Pain Capacity by Manufacturers
      • 3.1.2 Global Osteoarthritis Pain Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Osteoarthritis Pain Revenue by Manufacturers (2014-2019)
      • 3.2.2 Osteoarthritis Pain Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
    • 3.3 Osteoarthritis Pain Price by Manufacturers
    • 3.4 Key Manufacturers Osteoarthritis Pain Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Osteoarthritis Pain Market
    • 3.6 Key Manufacturers Osteoarthritis Pain Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Oral Production and Production Value (2014-2019)
      • 4.1.2 Non-Oral Production and Production Value (2014-2019)
    • 4.2 Global Osteoarthritis Pain Production Market Share by Type
    • 4.3 Global Osteoarthritis Pain Production Value Market Share by Type
    • 4.4 Osteoarthritis Pain Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Osteoarthritis Pain Consumption by Application

    6 Production by Regions

    • 6.1 Global Osteoarthritis Pain Production (History Data) by Regions 2014-2019
    • 6.2 Global Osteoarthritis Pain Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Osteoarthritis Pain Production Growth Rate 2014-2019
      • 6.3.2 United States Osteoarthritis Pain Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Osteoarthritis Pain Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Osteoarthritis Pain Production Growth Rate 2014-2019
      • 6.4.2 European Union Osteoarthritis Pain Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Osteoarthritis Pain Import & Export
    • 6.5 China
      • 6.5.1 China Osteoarthritis Pain Production Growth Rate 2014-2019
      • 6.5.2 China Osteoarthritis Pain Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Osteoarthritis Pain Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Osteoarthritis Pain Consumption by Regions

    • 7.1 Global Osteoarthritis Pain Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Osteoarthritis Pain Consumption by Type
      • 7.2.2 United States Osteoarthritis Pain Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Osteoarthritis Pain Consumption by Type
      • 7.3.2 European Union Osteoarthritis Pain Consumption by Application
    • 7.4 China
      • 7.4.1 China Osteoarthritis Pain Consumption by Type
      • 7.4.2 China Osteoarthritis Pain Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Osteoarthritis Pain Consumption by Type
      • 7.5.2 Rest of World Osteoarthritis Pain Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Abbott Laboratories
      • 8.1.1 Abbott Laboratories Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Osteoarthritis Pain
      • 8.1.4 Osteoarthritis Pain Product Introduction
      • 8.1.5 Abbott Laboratories Recent Development
    • 8.2 Johnson & Johnson
      • 8.2.1 Johnson & Johnson Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Osteoarthritis Pain
      • 8.2.4 Osteoarthritis Pain Product Introduction
      • 8.2.5 Johnson & Johnson Recent Development
    • 8.3 Novartis International
      • 8.3.1 Novartis International Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Osteoarthritis Pain
      • 8.3.4 Osteoarthritis Pain Product Introduction
      • 8.3.5 Novartis International Recent Development
    • 8.4 Pfizer
      • 8.4.1 Pfizer Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Osteoarthritis Pain
      • 8.4.4 Osteoarthritis Pain Product Introduction
      • 8.4.5 Pfizer Recent Development
    • 8.5 AbbVie
      • 8.5.1 AbbVie Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Osteoarthritis Pain
      • 8.5.4 Osteoarthritis Pain Product Introduction
      • 8.5.5 AbbVie Recent Development
    • 8.6 Abiogen Pharma
      • 8.6.1 Abiogen Pharma Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Osteoarthritis Pain
      • 8.6.4 Osteoarthritis Pain Product Introduction
      • 8.6.5 Abiogen Pharma Recent Development
    • 8.7 Afferent Pharmaceuticals
      • 8.7.1 Afferent Pharmaceuticals Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Osteoarthritis Pain
      • 8.7.4 Osteoarthritis Pain Product Introduction
      • 8.7.5 Afferent Pharmaceuticals Recent Development
    • 8.8 Astellas Pharma
      • 8.8.1 Astellas Pharma Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Osteoarthritis Pain
      • 8.8.4 Osteoarthritis Pain Product Introduction
      • 8.8.5 Astellas Pharma Recent Development
    • 8.9 BioDelivery Sciences International
      • 8.9.1 BioDelivery Sciences International Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Osteoarthritis Pain
      • 8.9.4 Osteoarthritis Pain Product Introduction
      • 8.9.5 BioDelivery Sciences International Recent Development
    • 8.10 Crystal Genomics
      • 8.10.1 Crystal Genomics Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Osteoarthritis Pain
      • 8.10.4 Osteoarthritis Pain Product Introduction
      • 8.10.5 Crystal Genomics Recent Development
    • 8.11 Cytori Therapeutics

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Osteoarthritis Pain Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Osteoarthritis Pain Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Osteoarthritis Pain Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Osteoarthritis Pain Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Osteoarthritis Pain Production Forecast by Type
      • 9.7.2 Global Osteoarthritis Pain Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Osteoarthritis Pain Sales Channels
      • 10.2.2 Osteoarthritis Pain Distributors
    • 10.3 Osteoarthritis Pain Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Osteoarthritis Pain . Industry analysis & Market Report on Osteoarthritis Pain is a syndicated market report, published as Global (United States, European Union and China) Osteoarthritis Pain Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Osteoarthritis Pain market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,532.16
      3,798.24
      5,064.32
      3,014.32
      4,521.48
      6,028.64
      498,789.60
      748,184.40
      997,579.20
      276,044.80
      414,067.20
      552,089.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report